Boehringer Ingelheim

For Healthcare Professionals

Logout

Boehringer Ingelheim

Boehringer Ingelheim

Boehringer Ingelheim

Therapeutic Area
Therapeutic Area

At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. As a successful, family owned company we plan in generations. We work together globally and with integrity. Our Focus articulates who we are and what we strive for, how we work and what we want to achieve.

Section Overview

Therapeutic Area

Section Overview

Oncology

Inflammation

Respiratory
Products
Products

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products.

See All Products

Products

See All Products
Resources
Contact
Logout

Boehringer Ingelheim

Glyxambi
Prescribing information
Voice of CRM
Heart Failure Got Treatment
Champs Opens in new tab
Prof Merlin Thomas CKD Video Series
Prof Christoph Wanner’s take on EMPA-KIDNEY
Videos
Let's Talk

JARDIANCE^® provides triple protection in your patients with CRM conditions:

How do you recognise a HF patient?

29/03/2023 | Author: Boehringer Ingelheim

Document ID: PC-MY-102918

Heart Failure Got Treatment

What is doctor’s experience on Jardiance safety profile?

What benefits would Jardiance provide to your patients?

How does Jardiance simplify HF treatment?

Are the Benefits of Jardiance similar in both HFrEF and HFpEF treatment?

What is the value of Jardiance in HF treatment?

How does Jardiance change the way physician treat HF?

How do you recognise a HF patient?

What is the Biggest Unmet Need in HF Treatment?

What do you look forward the most with the latest indication of Jardiance?

What do you think of the latest ESC Guidelines on treatment for HF?

How soon can we initiate SGLT2i treatment in your HF patients?

RELATED CONTENT

HFGT||What is the Biggest Unmet Need in HF Treatment?

3:07

What is the Biggest Unmet Need in HF Treatment?

Watch now Opens in new tab

HFGT||What do you look forward the most with the latest indication of Jardiance?

4:04

What do you look forward the most with the latest indication of Jardiance?

Watch now Opens in new tab

What do you think of the latest ESC Guidelines on treatment for HF?

3:01

What do you think of the latest ESC Guidelines on treatment for HF?

Watch now Opens in new tab

How soon can we initiate SGLT2i treatment in your HF patients?

3:29

How soon can we initiate SGLT2i treatment in your HF patients?

Watch now Opens in new tab

Home
Metabolic
Empagliflozin
Heart Failure Got Treatment
How do you recognise a HF patient?

Sitemap

Therapeutic Area

Resources
- Videos
- Clinical studies

BI logo

Privacy
Terms of use
Sitemap
Contact

This website is intended for healthcare professionals in Malaysia. The contents of this website are for information purposes only and are not intended to substitute for advice, treatment or recommendations of a healthcare professional. For your health concerns and other questions about symptoms, treatment or medication, consult a healthcare professional.

Copyright © 2025 Boehringer Ingelheim (Malaysia) Sdn Bhd.
All rights reserved. Use of this site is subject to the Terms of Use and Privacy Statement.